T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCK
601
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $102M | 0.02% |
3,455,236
-2,414,869
| -41% | -$73M |
|
|
LABL
602
DELISTED
Multi-Color Corp
LABL
| $102M | 0.02% |
1,466,996
+1,280
| +0.1% | +$81.3K |
|
|
HME
603
DELISTED
HOME PROPERTIES, INC
HME
| $102M | 0.02% |
1,466,675
+966,965
| +194% | +$66.9M |
|
604
Strategic Education
STRA
$1.81B
| $102M | 0.02% |
1,900,826
+149,296
| +9% | +$9.6M |
|
|
FITB
605
Fifth Third Bancorp
FITB
$52.6B
| $101M | 0.02% |
5,374,774
-11,200
| -0.2% | -$211K |
|
|
ENDP
606
DELISTED
Endo International plc
ENDP
| $101M | 0.02% |
1,128,622
+914,907
| +428% | +$76.5M |
|
|
GEVA
607
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $101M | 0.02% |
1,037,935
+547,235
| +112% | +$57.9M |
|
608
America Movil
AMX
$69.7B
| $101M | 0.02% |
4,940,760
-121,050
| -2% | -$2.59M |
|
609
Yum! Brands
YUM
$41B
| $101M | 0.02% |
1,776,887
-636,070
| -26% | -$34.7M |
|
610
DuPont de Nemours
DD
$19.5B
| $100M | 0.02% |
823,626
-16,816
| -2% | -$2M |
|
|
CMA
611
DELISTED
Comerica
CMA
| $99.9M | 0.02% |
2,214,565
+1,918,144
| +647% | +$85.6M |
|
612
Matthews International
MATW
$725M
| $99.8M | 0.02% |
1,937,190
+98,800
| +5% | +$4.76M |
|
|
ALOG
613
DELISTED
Analogic Corp
ALOG
| $99M | 0.02% |
1,088,962
-100,112
| -8% | -$8.61M |
|
614
Cognex
CGNX
$10.2B
| $98.9M | 0.02% |
3,987,954
+72,088
| +2% | +$1.53M |
|
615
HP
HPQ
$26.8B
| $98.3M | 0.02% |
6,947,312
+47,233
| +0.7% | +$779K |
|
|
AEC
616
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $98.1M | 0.02% |
3,975,290
+4,980
| +0.1% | +$122K |
|
617
Bloomin' Brands
BLMN
$975M
| $97.4M | 0.02% |
4,001,744
+36,358
| +0.9% | +$905K |
|
618
Lockheed Martin
LMT
$140B
| $97.2M | 0.02% |
478,799
-294,095
| -38% | -$58.1M |
|
619
Alcoa
AA
$13.5B
| $97.1M | 0.02% |
3,126,368
+157,149
| +5% | +$5.64M |
|
620
Phillips 66
PSX
$90B
| $96.9M | 0.02% |
1,233,259
-1,339,964
| -52% | -$98.3M |
|
|
KNGT
621
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $96.5M | 0.02% |
2,991,587
+24,320
| +0.8% | +$784K |
|
622
Brinker International
EAT
$10.5B
| $96.4M | 0.02% |
1,566,464
+10,870
| +0.7% | +$654K |
|
623
Descartes Systems
DSGX
$6.65B
| $96.3M | 0.02% |
6,395,679
+19,844
| +0.3% | +$300K |
|
624
Flotek Industries
FTK
$1.35B
| $96.3M | 0.02% |
1,089,017
+128,723
| +13% | +$12.6M |
|
|
TFCF
625
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $96.1M | 0.02% |
2,923,440
-537,200
| -16% | -$18M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.